Investor Relations

CHF Solutions is an early stage company focused on commercializing the Aquadex FlexFlow® system. Our objective is to improve the quality of life for patients with heart failure and related conditions, such as fluid overload. CHF Solutions is listed on the NASDAQ Capital Market.

Press Releases

CHF Solutions to Participate in the 6th Annual Intellisight Investor Conference on Tuesday, August 22, 2017
Posted on Aug 16, 2017
EDEN PRAIRIE, Minn., Aug. 16, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that John Erb, CEO, will be a featured presenter at the 6th Annual Intellisight Conference on Tuesday, August 22, 2017 from 3:35pm - 4:10pm central time in Minneapolis. Interested parties can v...

Read More

CHF Solutions, Inc. Announces 18% Revenue Growth for its Second Quarter and Provides Company Update
Posted on Aug 8, 2017
EDEN PRAIRIE, Minn., Aug. 08, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today its second quarter results for the period ending June 30, 2017, which included the following highlights: Revenue for second quarter ended June 30, 2017 increased 18% compared to the same p...

Read More

CHF Solutions Commences Manufacturing Transition of Aquadex FlexFlow® System to its Minnesota Facility
Posted on Aug 3, 2017
EDEN PRAIRIE, Minn., Aug. 03, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that it has begun the process of transitioning the manufacturing of the Aquadex FlexFlow System from an indirect subsidiary of Baxter International, Inc. (NYSE:BAX), a global leader in the hosp...

Read More

View all press releases »

Events & Presentations

6th Annual Intellisight Investor Conference
Posted on Aug 22, 2017 at 3:35 PM CT
View all events & presentations »